Image

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking.

The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months.

The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.

Eligibility

Inclusion Criteria:

  • 18 years of age and older
  • Current cigarette smoker who is ambivalent about smoking
  • Not actively using any treatment to quit smoking
  • Own and regularly use a smartphone
  • State willingness to install and use their assigned app
  • Willingness to receive study communications
  • Smoke at least half a pack a day
  • Meet geolocation requirements

Exclusion Criteria:

  • A lifetime history of dementia or psychosis
  • Visual impairments that prevent viewing phone content and they lack adaptive devices
  • Report medical contra-indications for over-the-counter NRT use
  • Due to the potential for bias introduced by fraudulent participants, other exclusions will be applied to deter fraudulent enrollment.

Study details
    Smoking Behaviors

NCT07459621

Kaiser Permanente

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.